Clene Net Cash Flow 2018-2025 | CLNN

Clene net cash flow from 2018 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.

Clene Net Cash Flow 2018-2025 | CLNN

Clene net cash flow from 2018 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$231.3B
Amgen (AMGN)$153.3B
Gilead Sciences (GILD)$137.2B
Vertex Pharmaceuticals (VRTX)$96.3B
Bristol Myers Squibb (BMY)$92.3B
CSL (CSLLY)$83.7B
GSK (GSK)$76.6B
Regeneron Pharmaceuticals (REGN)$60.4B
Alnylam Pharmaceuticals (ALNY)$57B
Argenex SE (ARGX)$41.1B
BioNTech SE (BNTX)$26.8B
Royalty Pharma (RPRX)$20.8B
Insmed (INSM)$20.7B
Biogen (BIIB)$18.7B
Incyte (INCY)$15.3B
Illumina (ILMN)$14.7B
Genmab (GMAB)$14.6B
Genmab (GNMSF)$14.3B
Ascendis Pharma (ASND)$11.6B
BioMarin Pharmaceutical (BMRN)$11.4B
QIAGEN (QGEN)$10.7B
Swedish Orphan Biovitrum (BIOVF)$10.6B
Moderna (MRNA)$10.4B
Exelixis (EXEL)$10.1B
Verona Pharma American Depositary Share (VRNA)$9B
Blueprint Medicines (BPMC)$8.3B
Exact Sciences (EXAS)$8.2B
Bio-Techne Corp (TECH)$7.9B
Roivant Sciences (ROIV)$7.9B
Halozyme Therapeutics (HALO)$7.7B